Filling the need for trusted information on national health issues

Experts At European Parliament Session Outline Challenges In TB Drug Development

EurActiv: Developing countries urged to produce TB vaccines locally
“Even though one third of the global population have the microbes that cause tuberculosis (TB), pharmaceutical companies still have little incentive to produce the drugs that can combat the deadly but curable disease. Speaking at the European Parliament on Wednesday (21 January) Dr. Lucica Ditiu, executive secretary of [the] Stop TB Partnership, an international body coordinating the fight against tuberculosis among government bodies, donors, and NGOs, underlined the huge global health burden of tuberculosis…” (1/23).